x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DIA-0243338
| Product Information | |
|---|---|
| Formula | C30H28F4N6O5 |
| Molecular Weight | 628.57 |
| SMILES | FC(F)(F)C1=CC=C(COC2=CC=CC(N3C=NN(CC4=NC(C(F)=CC(C(O)=O)=C5)=C5N4C[C@@H]6CCO6)CC3)=N2)C(OC)=C1 |
| Target | GLP Receptor |
| Product Description | GLP-1 receptor agonist 10 (compound 42) is an agonist of GLP Receptor. GLP-1 receptor agonist 10 inhibits food intake and reduces glucose excursion in mice. GLP-1 receptor agonist 10 can be used in the study of type 2 diabetes (T2DM) and obesity. |
| Format & Storage | |
|---|---|
| Format | Solid |
| Color | Off-white to yellow |
| Purity | 99.51% |
| Shipping | Room temperature in the continental U.S. Other areas may vary. |
| Storage | Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 6 months; -20°C, 1 month |
| Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
